CICC: Maintains YUE YUEN IND (00551) target price at HK$15.64, maintains "Outperform" rating.
CICC expects the manufacturing business to see margins bottom out and recover in 2027, supported by a low base resulting from multiple headwinds such as raw materials and tariffs.
CICC released a research report stating that it basically maintains its earnings forecasts for YUE YUEN IND (00551) for 2026 and 2027 at US$201 million and US$236 million, respectively. The current share price corresponds to P/E ratios of 14x for 2026 and 12x for 2027. The bank maintains the company's "Outperform" rating and a target price of HK$15.64, corresponding to P/E ratios of 16x for 2026 and 14x for 2027, implying 15% upside from the current price.
CICC's main views are as follows:
Q3 2026 results in line with expectations
The company announced its results for the first three quarters of 2026: revenue of US$5.889 billion, down 2% year on year; net profit attributable to shareholders of US$134 million, down 52% year on year. Q3 2026 revenue was US$1.917 billion, down 2% year on year; net profit attributable to shareholders was US$62 million, down 42% year on year. Results were in line with the bank's expectations.
Manufacturing business: revenue decline narrowed, gross margin rebounded sequentially
On revenue, Q3 2026 manufacturing revenue fell 2% year on year to US$1.405 billion, a narrower decline than the 4% in Q2 2026, mainly because pull-forward orders were effective, the year-on-year decline in shipment volume narrowed to 4%, and product mix optimization drove a 2% year-on-year increase in footwear average selling price (ASP). On profitability, Q3 2026 gross margin fell 3.3 percentage points year on year to 16.1%, but rebounded 2.3 percentage points sequentially, mainly due to sequential improvement in production efficiency and easing pressure from labor and manufacturing expenses, though rising raw material costs remained a drag. In addition, there was a one-off reversal of approximately US$11.2 million related to a tax dispute. Overall, net margin attributable to shareholders fell 3.2 percentage points year on year to 4.4%, and net profit attributable to shareholders fell 43% year on year to US$62 million.
Retail business: strict discount control widened revenue decline, gross margin improved year on year
Q3 2026 revenue of POU SHENG INT'L (03813) fell 8% year on year to RMB3.438 billion, a wider decline than the 3% in Q2 2026. As of the end of Q3 2026, the number of stores decreased by 256 from the beginning of the period to 3,054. Benefiting from inventory age optimization and improved discounts, quarterly gross margin rose about 0.8 percentage points year on year to 34.2%; net profit attributable to shareholders narrowed from a loss of RMB17 million in the same period last year to a loss of RMB6 million. On inventory, affected by stocking for e-commerce festivals in Q4 2026 and the timing of internal inventory management, inventory turnover days in Q3 2026 increased by 11 days year on year to 172 days.
Development trends
Q4 2026 is the traditional peak season. Management expects manufacturing shipment volume to potentially turn positive year on year, but this still depends on terminal sales in November and December and the effect of pull-forward orders; ASP is expected to decline year on year under a high base, with full-year ASP remaining stable, and Q4 2026 gross margin still under year-on-year pressure given the high base. The bank expects the manufacturing business to achieve a bottoming-out and recovery in profit margin in 2027 under the low base brought by multiple headwinds such as raw materials and tariffs. On the retail business, with Nike (NKE.US) taking back online channels starting in 2027, Pou Sheng has chosen to strictly control discounts to safeguard profitability, diverting inventory to off-season sales, franchisees, and replenishment at its own new stores, and reducing procurement for online business in 2027, while offline stores continue to operate normally, with sales to be offset through own brands and exclusively distributed brands.
Risk warnings
Orders below expectations, capacity expansion and ramp-up below expectations, raw material price fluctuations.
Related Articles

HK Stock Market Move | ENVISION GREEN (01783) opens nearly 10% higher; the company has once again locked in GPU supply through a signed agreement and has secured more than 30,000 GPU servers in supply.

Orient: The dividend investment strategy in the chemical sector deserves attention; focus on two categoriesresource-based and manufacturing-based.

HK Stock Market Move | JW THERAP-B (02126) opened nearly 15% higher; CAR-T drug Relma-cel included in the medical insurance catalog.
HK Stock Market Move | ENVISION GREEN (01783) opens nearly 10% higher; the company has once again locked in GPU supply through a signed agreement and has secured more than 30,000 GPU servers in supply.

Orient: The dividend investment strategy in the chemical sector deserves attention; focus on two categoriesresource-based and manufacturing-based.

HK Stock Market Move | JW THERAP-B (02126) opened nearly 15% higher; CAR-T drug Relma-cel included in the medical insurance catalog.






